Calypte Biomedical Corp (fka CBMC)

[bloodhound99]

Questions for the CC

A. AMEX delisting :

1. When will it occur?
2. What will new symbol be when moved to OTC?
3. Will the loss of the AMEX listing allow Marr to foreclose
on their loans to Calypte, or has this condition of
default been removed or "expunged" from the loan
agreements?

B. SFDA approval

1. Why is it being addressed in September? What happened
to requirement that an answer be given in 100 or 120
days?
2. What information is Calypte "collecting" that they feel
SFDA may need when it reviews their submission in Sept.?
3. Do they have any orders for the rapid oral test in China
pending SFDA approval?
4. It was announced that the China plant needed to be
recertified by 6-18-2006. Did this happen? If not, why
not? If not when will this occur?
5. Is it true that 30 new employees were hired in China at
the new plant increasing total employees there to about
80? Who is paying the salaries of those 80 employees?

C. Financing

1. In October 2005 Roger Gale said marr could finance Calypte to profitability with straight debt financing and no new dilution.